PROTON PUMP INHIBITORS (PPI) USE AND CLOSTRIDIUM DIFFICILE INFECTION: GUILTY OR INNOCENT BYSTANDER?

被引：0
|
作者：
Srinivas, M. [1 ,2 ]
Kerrane, A. [3 ]
Ahuja, S. [4 ]
Hilton, J. [3 ]
Hughes, C. [3 ]
Basumani, P. [2 ]
Bardhan, K. [2 ]
机构：
[1] Global Hosp & Hlth City, Dept Gastroenterol, Madras, Tamil Nadu, India
[2] Rotherham Hosp NHS Fdn Trust, Dept Gastroenterol, Rotherham, S Yorkshire, England
[3] Rotherham Hosp NHS Fdn Trust, Dept Microbiol & Infect Control, Rotherham, S Yorkshire, England
[4] Rotherham Hosp NHS Fdn Trust, Dept Pharm, Rotherham, S Yorkshire, England
来源：
GUT | 2012年 / 61卷
关键词：
D O I：
10.1136/gutjnl-2012-302514d.174
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A367 / A367
页数：1
相关论文
共 50 条
  • [41] PROTON PUMP INHIBITORS AND RISK FOR RECURRENT CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA
    Linsky, A.
    Gupta, K.
    Lawler, E.
    Fonda, J.
    Sokolovskaya, G.
    Hermos, J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 148 - 149
  • [42] Proton pump inhibitors increase risk of Clostridium infection
    Reactions Weekly, 2004, 1015 (1) : 5 - 5
  • [43] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
    Trifan, Anca
    Stanciu, Carol
    Girleanu, Irina
    Stoica, Oana Cristina
    Singeap, Ana Maria
    Maxim, Roxana
    Chiriac, Stefan Andrei
    Ciobica, Alin
    Boiculese, Lucian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (35) : 6500 - 6515
  • [44] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
    Anca Trifan
    Carol Stanciu
    Irina Girleanu
    Oana Cristina Stoica
    Ana Maria Singeap
    Roxana Maxim
    Stefan Andrei Chiriac
    Alin Ciobica
    Lucian Boiculese
    World Journal of Gastroenterology, 2017, (35) : 6500 - 6515
  • [45] Role of Proton Pump Inhibitors in Recurrence of Clostridium difficile Infection: Systematic Review and Meta-Analysis
    Tey, Kai Rou
    Singh, Nirmal
    Takyar, Varun
    Trowers, Eugene
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S449 - S450
  • [46] Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?
    Patil, Rashmee
    Blankenship, Leann
    GASTROENTEROLOGY RESEARCH, 2013, 6 (05) : 171 - 173
  • [47] Risk and Severity of Hospital-Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors
    Lewis, Paul O.
    Litchfield, John M.
    Tharp, Jennifer L.
    Garcia, Rebecca M.
    Pourmorteza, Mohsen
    Reddy, Chakradhar M.
    PHARMACOTHERAPY, 2016, 36 (09): : 986 - 993
  • [48] Are proton pump inhibitors associated with an increased risk of Clostridium difficile infection after considering confounding variables?
    Hughes, K.
    Lalikian, K. A.
    Schwartz, J.
    Turner, R. B.
    JOURNAL OF HOSPITAL INFECTION, 2017, 95 (04) : 445 - 446
  • [49] Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection
    Hegarty, John P.
    Sangster, William
    Harris, Leonard R., III
    Stewart, David B.
    SURGERY, 2014, 156 (04) : 972 - 978
  • [50] Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection (vol 170, pg 772, 2010)
    Linsky
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (13) : 1100 - 1100
12345